Volume 576 Issue 7785, 5 December 2019
Editorial | 04 December 2019
Expensive treatments for genetic disorders are arriving. But who should foot the bill?
The majority of people with sickle-cell disease are live in the world’s poorest communities and cannot afford the eye-watering costs of treatments.